Tyler Bussian
Stock Analyst at Brookline Capital
(0.12)
# 4,248
Out of 5,178 analysts
5
Total ratings
25%
Success rate
-29.08%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tyler Bussian
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COCH Envoy Medical | Initiates: Buy | $9 | $0.69 | +1,198.70% | 1 | Oct 14, 2024 | |
| CRVO CervoMed | Initiates: Buy | $63 | $3.92 | +1,507.14% | 1 | Jul 8, 2024 | |
| IMUX Immunic | Initiates: Buy | $10 | $1.26 | +693.65% | 1 | Apr 5, 2024 | |
| ANVS Annovis Bio | Downgrades: Hold | $9 | $2.15 | +318.60% | 2 | Feb 28, 2024 |
Envoy Medical
Oct 14, 2024
Initiates: Buy
Price Target: $9
Current: $0.69
Upside: +1,198.70%
CervoMed
Jul 8, 2024
Initiates: Buy
Price Target: $63
Current: $3.92
Upside: +1,507.14%
Immunic
Apr 5, 2024
Initiates: Buy
Price Target: $10
Current: $1.26
Upside: +693.65%
Annovis Bio
Feb 28, 2024
Downgrades: Hold
Price Target: $9
Current: $2.15
Upside: +318.60%